Drug
Ab102
Ab102: highest development phase Phase 1, developed by Arcus Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Arcus Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| AB102 NCT07662057 | Phase 1 |
Latest
No recent events.
Follow Ab102 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.